For: | Qu CY, Zhang FY, Wang W, Gao FY, Lin WL, Zhang H, Chen GY, Zhang Y, Li MM, Li ZH, Cai MH, Xu LM, Shen F. Endoscopic polidocanol foam sclerobanding for the treatment of grade II-III internal hemorrhoids: A prospective, multi-center, randomized study. World J Gastroenterol 2024; 30(27): 3326-3335 [PMID: 39086750 DOI: 10.3748/wjg.v30.i27.3326] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v30/i27/3326.htm |
Number | Citing Articles |
1 |
An-Na Mou, Yu-Ting Wang. Endoscopic polidocanol foam sclerobanding for treatment of internal hemorrhoids: A novel outpatient procedure. World Journal of Gastroenterology 2024; 30(42): 4583-4586 doi: 10.3748/wjg.v30.i42.4583
|
2 |
|
3 |
Yu-Yan Zhang, Bing Hu. Endoscopic polidocanol foam sclerobanding for the treatment of Grade II-III internal hemorrhoids: The focus of clinical practice. World Journal of Gastroenterology 2024; 30(38): 4246-4248 doi: 10.3748/wjg.v30.i38.4246
|
4 |
Asad Gul Rao, Abdulqadir J Nashwan. Redefining hemorrhoid therapy with endoscopic polidocanol foam sclerobanding. World Journal of Gastroenterology 2024; 30(36): 4021-4024 doi: 10.3748/wjg.v30.i36.4021
|
5 |
Gianpiero Gravante. Sclerotherapy for hemorrhoidal disease: Recent evolutions of an oldies goldy. World Journal of Gastroenterology 2025; 31(8): 98704 doi: 10.3748/wjg.v31.i8.98704
|